The SELECT trial establishing semaglutides 20% reduction in major adverse cardiovascular events has converted GLP-1 receptor agonists from single-indication obesity drugs into foundational chronic disease therapeutics demanding continuous prescription renewal
News provided by Novo Nordisk Aug 18, 2025, 09:00 ET Offer supports access for eligible patients without insurance to FDA-approved Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg, the GLP-1 medicine with the broadest range of FDA-approved indications for adults with type 2 diabetes 1 For the first time, Ozempic is available via home delivery through NovoCare Pharmacy
Injectable, oral, and sublingual formulations each have distinct considerations worth understanding
Se evalu la farmacocintica de semaglutida en pacientes con insuficiencia heptica leve, moderada o grave en comparacin con personas con funcin heptica normal en un estudio en el que se administraba semaglutida una vez al da durante 10 das consecutivos
Differences in Efficacy of Weight Reduction of Oral Semaglutide in Asians and Non-Asians The same method was used to assess the effectiveness of 3-, 7-, and 14-mg doses of oral semaglutide for weight reduction in Asian and non-Asian subgroups
Beyond just featuring the same active ingredient as the headline-making injections, heres what else you need to know: Oral semaglutide is FDA-approved for diabetes (Rybelsus) and for weight loss (Wegovy pill)
